logo
AAT Bioquest

 
search
logo
AAT Bioquest
Image Gallery
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
 
search
calculatorCalculator

C-X-C chemokine receptor type 3 Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
Amg-487IC5015.0 [1]
Amg-487Ki39.81 [1], 158.49 [2]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC50115.0 [1]
N-(2-Ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-[(1R)-1-[4-oxo-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidin-2-yl]ethyl]acetamideIC500.4 [1], 0.6 [2], 0.8 [3], 15.0 [4]
N-[(1R)-1-[3-(4-Cyanophenyl)imidazo[1,2-a]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC50643.0 [1]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC5047.0 [1], 129.0 [2]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[1,2-a]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC502.0 [1], 17.0 [2], 41.0 [3]
(6Ar,9R)-9-N,9-N-diethyl-7-N-phenyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-7,9-dicarboxamideIC5018.0 [1], 51.0 [2], 54.0 [3], 74.0 [4]
1-(4-Chlorophenyl)-2-(2-imino-3-methyl-benzimidazol-1-yl)ethanoneIC50800.0 [1], 9000.0 [2]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-[(1-oxidopyridin-1-ium-3-yl)methyl]-2-[4-(trifluoromethoxy)phenyl]acetamideIC504.0 [1], 7.0 [2], 14.0 [3], 58.0 [4]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC500.9 [1], 7.3 [2], 18.9 [3], 21.0 [4]
5-Chloro-6-(4-(1-(4-cyanobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(2-phenoxyethyl)nicotinamideIC5020.0 [1], 45.0 [2], 85.0 [3]
5-Chloro-6-(4-(1-(4-cyanobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(2-phenoxyethyl)nicotinamideKi110.0 [1]
N-[(1R)-1-[3-(4-Chlorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC506.0 [1], 9.8 [2], 12.0 [3], 45.0 [4]
4-[[1-(2,3-Dihydro-1-benzofuran-5-yl)ethyl-[[4-[2-(2,5-dioxopyrrolidin-1-yl)ethoxy]-3-methoxyphenyl]methyl]amino]methyl]cyclohexane-1-carboxylic acidIC5060.0 [1], 760.0 [2]
4-[[(5-Chloro-2,3-dihydro-1H-inden-1-yl)-[[4-[2-(2,5-dioxopyrrolidin-1-yl)ethoxy]-3-methoxyphenyl]methyl]amino]methyl]cyclohexane-1-carboxylic acidIC5024.0 [1], 64.0 [2], 1660.0 [3]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamideIC505.0 [1], 20.0 [2]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamideKi10.0 [1]
3-Amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]pyrazine-2-carboxamideIC500.8 [1]
3-Amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]pyrazine-2-carboxamideKi0.4 [1]
CXCR3 Antagonist 6cIC5020.0 [1], 60.0 [2], 100.0 [3]
(S)-5-Chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamideIC500.3 [1]
(S)-5-Chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamideKi3.16 [1]
1-(4-Chlorophenyl)-2-(4-ethyl-2-imino-3-methylbenzimidazol-1-yl)ethanoneIC5030.0 [1], 70.0 [2]
N-[2-(Dimethylamino)ethyl]-N-[1-[3-(4-fluorophenyl)-4-oxoquinazolin-2-yl]ethyl]decanamideIC50250.0 [1], 500.0 [2], 3200.0 [3]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxoquinazolin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamideIC506.0 [1], 7.0 [2], 140.0 [3]
N-[(1R)-1-[1-(4-Cyanophenyl)-4-phenylimidazol-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC500.7 [1], 14.0 [2]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxoquinazolin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamideIC501.0 [1], 3.0 [2], 20.0 [3]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxoquinazolin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenyl]acetamideIC506.0 [1], 350.0 [2]
N-[(1R)-1-[3-(4-Chlorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC507.0 [1], 13.0 [2], 55.0 [3]
N-[(1,1-Dioxothian-4-yl)methyl]-N-[(1R)-1-[3-(4-fluorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC507.0 [1], 22.0 [2], 90.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)quinolin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC500.8 [1], 21.0 [2], 72.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-1,8-naphthyridin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC502.0 [1], 27.0 [2], 48.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-methyl-4-oxo-6,7-dihydro-5H-pyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC504.0 [1], 60.0 [2], 88.0 [3]
N-[(1R)-1-[1-(4-Cyanophenyl)benzimidazol-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC506.0 [1], 35.0 [2], 521.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)imidazo[1,2-a]pyridin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC5021.0 [1], 72.0 [2]
N-[(1R)-1-[3-(4-Cyanophenyl)imidazo[1,2-a]pyridin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideKi3.0 [1]
N-[(1R)-1-[3-(4-Cyanophenyl)-7-methylimidazo[1,2-a]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC502.0 [1], 22.0 [2], 100.0 [3]
N-[1-[8-Chloro-3-(4-cyanophenyl)imidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC503.0 [1], 20.0 [2], 57.0 [3]
N-[1-[3-(4-Cyanophenyl)-8-methoxyimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC502.0 [1], 17.0 [2], 18.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-methoxyimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC500.9 [1], 6.0 [2], 7.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-methylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC501.6 [1], 10.0 [2], 44.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-ethylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC501.1 [1], 11.0 [2], 12.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC500.9 [1], 16.0 [2], 17.0 [3]
N-[1-[3-(4-Cyanophenyl)-8-(dimethylamino)imidazo[1,2-a]pyrazin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC501.4 [1], 27.0 [2], 45.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-(trifluoromethoxy)phenyl]acetamideIC501.1 [1], 13.0 [2], 34.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC500.9 [1], 21.0 [2], 25.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[3-(trifluoromethyl)phenyl]acetamideIC501.7 [1], 29.0 [2], 36.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-(trifluoromethyl)phenyl]acetamideIC501.3 [1], 16.0 [2], 22.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-8-cyclopropylimidazo[1,2-a]pyrazin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[3-(trifluoromethoxy)phenyl]acetamideIC501.1 [1], 25.0 [2], 75.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-7-methyl-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC504.0 [1], 12.0 [2], 30.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-7-methoxy-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC504.0 [1], 10.0 [2], 22.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-7-methoxy-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC503.0 [1], 7.0 [2], 18.0 [3]
(6Ar,9R)-9-(4-hydroxypiperidine-1-carbonyl)-N-phenyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-7-carboxamideIC505.0 [1], 14.0 [2], 200.0 [3]
(6Ar,9R)-N-phenyl-9-(pyrrolidine-1-carbonyl)-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-7-carboxamideIC504.0 [1], 5.0 [2], 700.0 [3]
(6Ar,9R)-N-phenyl-9-(piperidine-1-carbonyl)-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-7-carboxamideIC505.0 [1], 9.0 [2], 840.0 [3]
N-[(1,1-Dioxothian-4-yl)methyl]-N-[(1R)-1-[3-(4-fluorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC507.0 [1], 17.0 [2], 72.0 [3]
N-[(1R)-1-[3-(4-Chlorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC507.0 [1], 21.0 [2], 107.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC508.0 [1], 12.0 [2], 39.0 [3]
N-(2-Ethylsulfonylethyl)-N-[(1R)-1-[3-(4-fluorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC5047.0 [1], 58.0 [2], 292.0 [3]
N-[(1R)-1-[3-(4-Chlorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC506.0 [1], 22.0 [2], 102.0 [3]
N-(2-Ethylsulfonylethyl)-N-[(1R)-1-[3-(4-fluorophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC5042.0 [1], 50.0 [2], 254.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[3-fluoro-4-(trifluoromethyl)phenyl]acetamideIC507.0 [1], 15.0 [2], 37.0 [3]
N-[(1R)-1-[3-(4-Cyanophenyl)-4-oxopyrido[1,2-a]pyrimidin-2-yl]ethyl]-N-[(1,1-dioxothian-4-yl)methyl]-2-[4-(trifluoromethoxy)phenyl]acetamideIC506.0 [1], 22.0 [2], 60.0 [3]
N-[(Z)-1-(3-Acetamidophenyl)ethylideneamino]-4-[[benzyl-(4-chlorophenyl)sulfonylamino]methyl]benzamideIC50538.0 [1]
N-[(Z)-1-(3-Acetamidophenyl)ethylideneamino]-4-[[benzyl-(4-chlorophenyl)sulfonylamino]methyl]benzamideKi211.0 [1], 348.0 [2]
4-[[[(1S)-1-(4-Chlorophenyl)ethyl]-[[4-[2-(2,5-dioxopyrrolidin-1-yl)ethoxy]-3-methylphenyl]methyl]amino]methyl]cyclohexane-1-carboxylic acidIC5032.0 [1], 38.0 [2], 3810.0 [3]
(4-Chlorophenyl)methyl-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]-dimethylazaniumKi199.53 [1], 501.19 [2]
[4-(3-Chlorophenyl)phenyl]methyl-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]-dimethylazaniumKi125.89 [1], 251.19 [2], 316.23 [3]
5-Chloro-6-[(3S)-4-[1-[(4-chloro-2-fluorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-N-ethylpyridine-3-carboxamideIC500.2 [1]
5-Chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamideIC5035.0 [1]
5-Chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamideKi35.0 [1]
N-[(1R)-1-[3-(4-Hydroxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamideIC504.1 [1], 816.0 [2]
3-[1-[(4-Bromophenyl)methyl]piperidin-4-yl]-3-phenylpiperidine-2,6-dioneIC50330.0 [1], 1330.0 [2]
2-(2-Acetylbenzimidazol-1-yl)-1-(4-nitrophenyl)ethanoneIC503000.0 [1]
1-(4-Iodophenyl)-3-(2-adamantyl)guanidineKi3981.07 [1]
1-[3,5-Bis(trifluoromethyl)phenyl]-3-[1-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]piperidin-4-yl]ureaKi26.0 [1], 73.0 [2]
1-[1-[[(1R,5S)-6,6-Dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]piperidin-4-yl]-3-[3-fluoro-5-(trifluoromethyl)phenyl]ureaKi16.0 [1]
N-[1-[[(1R,5S)-6,6-Dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]piperidin-4-yl]-N-methyl-1,3-benzothiazol-2-amineKi126.0 [1], 140.0 [2]
1-[1-[(9-Acetyl-9-azabicyclo[3.3.1]non-2-en-3-yl)methyl]piperidin-4-yl]-3-[3-fluoro-5-(trifluoromethyl)phenyl]ureaKi9.0 [1]
5-Chloro-6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]piperazin-1-yl]-N-methylpyridine-3-carboxamideIC50560.0 [1]
5-Chloro-6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]piperazin-1-yl]-N-methylpyridine-3-carboxamideKi560.0 [1]
5-Chloro-6-[4-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]piperidin-1-yl]-N-[(3,4-dichlorophenyl)methyl]pyridine-3-carboxamideIC504500.0 [1]
5-Chloro-6-[4-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]piperidin-1-yl]-N-[(3,4-dichlorophenyl)methyl]pyridine-3-carboxamideKi4500.0 [1]
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC501.0 [1], 22.0 [2]
1-(1-(Cyclooctenylmethyl)piperidin-4-yl)-3-(naphthalen-2-yl)ureaKi110.0 [1]
N-[(1R)-1-[1-(4-Ethoxyphenyl)-4-phenylimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamideIC5011.0 [1], 91.0 [2]
(6Ar,9R)-9-(azetidine-1-carbonyl)-N-phenyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-7-carboxamideIC508.0 [1], 61.0 [2]
1-[2-[4-[[1-(2,3-Dihydro-1-benzofuran-5-yl)ethyl-methylamino]methyl]-2-methoxyphenoxy]ethyl]pyrrolidine-2,5-dioneIC5074.0 [1], 403.0 [2]
N-[2-[7-Chloro-3-[2-(4-chlorophenyl)-2-oxoethyl]-2-iminobenzimidazol-1-yl]ethyl]-N-methyl-2-phenylacetamideIC50300.0 [1], 400.0 [2]
1-(4-Chlorophenyl)-2-(2-imino-3,4-dimethylbenzimidazol-1-yl)ethanoneIC5080.0 [1], 100.0 [2]
N-[(1R)-1-[1-(4-Cyanophenyl)-4-cyclopropyl-5-(difluoromethyl)imidazol-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC5012.0 [1], 18.0 [2]
N-[(1R)-1-[5-Chloro-1-(4-cyanophenyl)-4-cyclopropylimidazol-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC507.8 [1], 24.0 [2]
N-[(1R)-1-[3-(4-Cyanophenyl)quinoxalin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC509.0 [1], 121.0 [2]
N-[(1R)-1-[2-(4-Cyanophenyl)quinolin-3-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC505.0 [1], 115.0 [2]
N-[(1R)-1-[3-(4-Cyanophenyl)pyrazolo[1,5-a]pyridin-2-yl]ethyl]-N-(2-ethylsulfonylethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamideIC5018.0 [1], 523.0 [2]
N-[3-[7-Chloro-3-[2-(4-chlorophenyl)-2-oxoethyl]-2-iminobenzimidazol-1-yl]propyl]-N-methylnaphthalene-2-carboxamideIC5015.0 [1], 40.0 [2]
N-[3-[7-Chloro-3-[2-(4-chlorophenyl)-2-oxoethyl]-2-iminobenzimidazol-1-yl]propyl]-N,2,2-trimethylpropanamideIC50400.0 [1], 600.0 [2]
N-[3-[3-[2-(4-Chlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamideIC50100.0 [1], 200.0 [2]
N-[4-[7-Chloro-3-[2-(4-chlorophenyl)-2-oxoethyl]-2-iminobenzimidazol-1-yl]butyl]-N-methyl-2-phenylacetamideIC50400.0 [1]
Items per page: 1 - 10 of 100
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ C-X-C chemokine receptor type 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Feb. 2025, https://www.aatbio.com/data-sets/c-x-c-chemokine-receptor-type-3-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2025, February 21). Quest Database™ C-X-C chemokine receptor type 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/c-x-c-chemokine-receptor-type-3-inhibitors-ic50-ki.
BibTeXEndNoteRefMan